Prognostic factor studies

Handbook of Statistics in Clinical Oncology: Second Edition

Volumn , Issue , 2005, Pages 289-333

  Schumacher, Martin ^a   Holländer, Norbert ^a   Schwarzer, Guido ^a   Sauerbrei, Willi ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123816329     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (165)

1. McGuire WL. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 1991;83:154-155.
2. Infante-Rivard C, Villeneuve J-P, Esnaola S. A framework for evaluating and conducting prognostic studies: an application to cirrhosis of the liver. J Clin Epidemiol 1989;42:791-805.
3. Clark GM, ed. Prognostic factor integration. Special issue. Breast Cancer Res Treat 1992;22:185-293.
4. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994;69:979-985.
5. Altman DG, Lyman GH. Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat 1998;52:289-303.
6. Wyatt JC, Altman DG. Prognostic models: clinically useful or quickly forgotten? Commentary. BMJ 1995;311:1539-1541.
7. Armitage P, Gehan EA. Statistical methods for the identification and use of prognostic factors. Int J Cancer 1974;13:16-36.
8. Byar DP. Analysis of survival data: Cox and Weibull models with covariates. In: Mike V, Stanley KE, eds. Statistics in Medical Research. New York: Wiley, 1982:365-401.
9. Byar DP. Identification of prognostic factors. In: Buyse ME, Staquet MJ, Sylvester RJ, eds. Cancer Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1984:423-143.
10. Simon R. Use of regression models: statistical aspects. In: Buyse ME, Staquet MJ, Sylvester RJ, eds. Cancer Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1984:444-466.
11. George SL. Identification and assessment of prognostic factors. Semin Oncol 1988; 5:462-471.
12. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cut-points in the evaluation of prognostic factors. Commentary. J Natl Cancer Inst 1994; 86:829-835.
13. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995;72:511-518.
14. Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind C. Prognostic Factors in Cancer. 2nd ed. Heidelberg, New York: Springer, 2001.
15. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Chichester: Wiley, 1995.
16. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. Chichester: Wiley, 1995.
17. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-694.
18. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies. 2004 (submitted).
19. Riley RD, Abrams KR, Sutton AJ, Lambert PC et al. Reporting of prognostic markers: current problems and development of guidelines for evidence based practice in the future. Br J Cancer 2003;88:1191-1198.
20. Altman DG. Systematic reviews of studies of prognostic variables. In: Egger M, Davey S, Altman D eds. Systematic Reviews in Health Care: Meta Analysis in Context. London: BHY Publ. group 2001:228-247.
21. Harris EK, Albert A. Survivorship Analysis for Clinical Studies. New York: Marcel Dekker, 1991.
22. Lee ET. Statistical Methods for Survival Data Analysis. 2nd ed. New York: Wiley, 1992.
23. Collett D. Modelling Survival Data in Medical Research. London: Chapman & Hall, 1994.
24. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer, 1997.
25. Therneau TM, Grambsch PM. Modeling Survival Data. New York: Springer, 2000.
26. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley, 1980.
27. Fleming TR, Harrington DP. Counting Processes and Survival Analysis. New York: Wiley, 1991.
28. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Methods Based on Counting Processes. New York: Springer, 1992.
29. Burke HB, Henson DE. Criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-3135.
30. Henson DE. Future directions for the American Joint Committee on Cancer. Cancer 1992;69:1639-1644.
31. Fielding LP, Fenoglio-Preiser CM, Freedman LS. The future of prognostic factors in outcome prediction for patients with cancer. Cancer 1992;70:2367-2377.
32. Fielding LP, Henson DE. Multiple prognostic factors and outcome analysis in patients with cancer. Cancer 1993;71:2426-2429.
33. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: LippincottRaven Publishers, 1998.
34. Simon R. Patients subsets and variation in therapeutic efficacy. Br J Cancer 1982; 14:473-482.
35. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985;41:361-372.
36. Byar DP. Assessing apparent treatment covariate interactions in randomized clinical trials. Stat Med 1985;4:255-263.
37. Schmoor C, Ulm K, Schumacher M. Comparison of the Cox model and the regression tree procedure in analyzing a randomized clinical trial. Stat Med 1993; 12:2351-2366.
38. Royston P, Sauerbrei W. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Stat Med 2004;23:2509-2525.
39. Bloom HJG, Richardson WW. Histological grading and prognosis in primary breast cancer. Br J Cancer 1957;2:359-377.
40. Pfisterer J, Kommoss F, Sauerbrei W, Menzel D, Kiechle M, Giese E, Hilgarth M, Pfleiderer A. DNA flow cytometry in node positive breast cancer: prognostic value and correlation to morphological and clinical factors. Anal Quant Cytol Histol 1995; 17:406-412.
41. Schumacher M, Bastert G, Bojar H, Hübner K, Olschewski M, Sauerbrei W, Schmoor C, Beyerle C, Neumann RLA, Rauschecker HF for the German Breast Cancer Study Group. Randomized 2 X 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. J Clin Oncol 1994; 12:2086-2093.
42. Schmoor C, Olschewski M, Schumacher M. Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med 1996;15:263-271.
43. Cox DR. Regression models and life tables (with discussion). J R Stat Soc, Ser. B 1972;34:187-220.
44. Schumacher M, Holländer N, Sauerbrei W. Reduction of bias caused by model building. Proceedings of the Statistical Computing Section, American Statistical Association, 1996; 1-7.
45. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48:73-85.
46. Hilsenbeck SG, Clark GM. Practical P-value adjustment for optimally selected cutpoints. Stat Med 1996; 15:103-112.
47. Worsley KJ. An improved Bonferroni inequality and applications. Biometrika 1982; 69:297-302.
48. Lausen B, Sauerbrei W, Schumacher M. Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales. In: Dirschedl P, Ostermann R, eds. Computational Statistics. Heidelberg: Physica-Verlag, 1994:1483-1496.
49. Lausen B, Schumacher M. Evaluating the effect of optimized cutoff values in the assessment of prognostic factors. Comput Stat Data Analyis 1996; 21:307-326.
50. Hothorn T, Lausen B. On the exact distribution of maximally selected rank statistics. Comput Stat Data Analyis 2003; 121-137.
51. Verweij P, Van Houwelingen HC. Cross-validation in survival analysis. Stat Med 1993;12:2305-2314.
52. Schumacher M, Holländer N, Sauerbrei W. Resampling and cross-validation techniques: a tool to reduce bias caused by model building. Stat Med 1997; 16:2813-2827.
53. Van Houwelingen HC, Le Cessie S. Predictive value of statistical models. Stat Med 1990;9:1303-1325.
54. Holländer N, Sauerbrei W, Schumacher M. Confidence intervals for the effect of a prognostic factor after selection of an "optimal" cutpoint. Stat Med 2004; 23:1701-1713.
55. Andersen PK. Survival analysis 1982-1991: the second decade of the proportional hazards regression model. Stat Med 1991;10:1931-1941.
56. Sauerbrei W. The use of resampling methods to simplify regression models in medical statistics. Appl Stat 1999;48:313-329.
57. Miller AJ. Subset Selection in Regression. London: Chapman and Hall, 1990.
58. Teräsvirta T, Mellin I. Model selection criteria and model selection tests in regression models. Scand J Stat 1986;13:159-171.
59. Mantel N. Why stepdown procedures in variable selection? Technometrics 1970;12:621-625.
60. Sauerbrei W. Comparison of variable selection procedures in regression models: a simulation study and practical examples. In: Michaelis J, Hommel G, Wellek S, eds. Europäische Perspektiven der Medizinischen Informatik, Biometrie und Epidemiologie. MMV: München, 1993:108-113.
61. Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461-464.
62. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling (with discussion). Appl Stat 1994;43:429-467.
63. Holländer N, Schumacher M. Estimating the functional form of a continuous covari-ate's effect on survival time. Comput Stat Data Anal 2005; in press.
64. Sauerbrei W, Royston P. Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. J R Stat Soc, Ser. A, 1999;162:71-94.
65. Sauerbrei W, Royston P, Bojar H, Schmoor C, Schumacher M and the German Breast Cancer Study Group (GBSG). Modelling the effects of standard prognostic factors in node positive breast cancer. Br J Cancer 1999; 79:1752-1760.
66. Harrell FE Jr. Regression Modelling Strategies, with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer, 2001.
67. Valsecchi MG, Silvestri D. Evaluation of long-term survival: use of diagnostics and robust estimators with Cox's proportional hazards model. Stat Med 1996; 15:2763-2780.
68. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387.
69. Hastie TJ, Tibshirani RJ. Generalized Additive Models. New York: Chapman and Hall, 1990.
70. Chen CH, George SL. The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. Stat Med 1985;4:39-46.
71. Altman DG, Andersen PK. Bootstrap investigation of the stability of a Cox regression model. Stat Med 1989;8:771-783.
72. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992; 11:2093-2109.
73. Royston P, Sauerbrei W. Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation. Stat Med, 2003; 22:639-659.
74. Breiman L, Friedman JH, Olshen R, Stone CJ. Classification and Regression Trees. Monterey: Wadsworth, 1984.
75. Zhang H, Crowley J, Sox HC, Olshen R. Tree-structured statistical methods. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Chichester: Wiley, 1998:4561-4573.
76. Gordon L, Olshen R. Tree-structured survival analysis. Can Treatm Rep 1985;69:1065-1069.
77. LeBlanc M, Crowley J. Relative risk regression trees for censored survival data. Biometrics 1992;48:411-425.
78. LeBlanc M, Crowley J. Survival trees by goodness of split. JASA 1993; 88:457-467.
79. Segal MR. Regression trees for censored data. Biometrics 1988; 44:35-47.
80. Segal MR. Tree-structured survival analysis in medical research. In: Everitt BS, Dunn G, eds. Statistical Analysis of Medical Data: New Developments. London: Arnold, 1998:101-125.
81. Ciampi A, Hendricks L, Lou Z. Tree-growing for the multivariate model: the RECPAM approach. In: Dodge Y, Whittaker J, eds. Computational Statistics. Vol 1. Heidelberg: Physica-Verlag, 1992:131-136.
82. Tibshirani R, LeBlanc M. A strategy for binary description and classification. J Comput Graph Stat 1992;1:3-20.
83. Sauerbrei W. On the development and validation of classification schemes in survival data. In: Klar R, Opitz O, eds. Classification and Knowledge Organization. Berlin, Heidelberg, New York: Springer, 1997:509-518.
84. Breiman L. Bagging predictors. Machine Learn 1996;24:123-140.
85. Friedman J, Hastie T, Tibshirani R. Additive logistic regression: a statistical view of boosting. Ann Stat 2000;2:334-374.
86. Breiman L. Random forests. Machine Learn 2001;45:5-32.
87. Diettrich TG. An experimental comparison of three methods for construting ensembles of decision trees: bagging, boosting, and randomization. Machine Learn 2000; 40:139-157.
88. Hothorn T, Lausen B, Benner A, Radespiel-Tröger M. Bagging survival trees. Stat Med 2003.
89. Breiman L. Statistical modeling: the two cultures (with comments and a rejoinder by the author). Stat Sci 2001;16:199-231.
90. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K. A prognostic index in primary breast cancer. Br J Cancer 1982; 45:361-366.
91. Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992;22:207-219.
92. Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 1994; 32:281-290.
93. Collett K, Skjaerven R, Machle BO. The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index. Breast Cancer Res Treat 1998;48:1-9.
94. Copas JB. Using regression models for prediction: shrinkage and regression to the mean. Stat Methods Med Res 1997;6:167-183.
95. Vach W. On the relation between the shrinkage effect and a shrinkage method. Comput Stat 1997;12:279-292.
96. Ripley BD. Pattern Recognition and Neural Networks. Cambridge: Cambridge University Press, 1996.
97. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995; 346:1135-1138.
98. Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet 1995; 346:1075-1079.
99. Dybowski R, Gant, V. Artificial neural networks in pathology and medical laboratories. Lancet 1995;346:1203-1207.
100. Wyatt J. Nervous about artificial neural networks? Lancet 1995;346:1175-1177.
101. Schwarzer G, Vach W, Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med 2000;19:541-561.
102. Penny W, Frost D. Neural networks in clinical medicine. Med Decis Making 1996; 16:386-398.
103. Cheng B, Titterington DM. Neural networks: a review from a statistical perspective (with discussion). Stat Sci 1994;9:2-54.
104. Ripley BD. Statistical aspects of neural networks. In: Barndorff-Nielsen OE, Jensen JL, eds. Networks and Chaos: Statistical and Probabilistic Aspects. London: Chapman and Hall, 1993: 40-123.
105. Schumacher M, Rossner R, Vach W. Neural networks and logistic regression: Part I. Comput Stat Data Anal 1996;21:661-682.
106. Stern HS. Neural networks in applied statistics (with discussion). Technometrics 1996;38:205-220.
107. Warner B, Misra M. Understanding neural networks as statistical tools. American Statistician 1996;50:284-293.
108. Hornik K, Stinchcombe M, White H. Multilayer feedforward networks are universal approximators. Neural Networks 1989;2:359-366.
109. Ripley RM. Neural network models for breast cancer prognosis. Ph.D. dissertation, University of Oxford, Dept. of Engineering Science, Oxford, 1998.
110. Liestøl K, Andersen PK, Andersen U. Survival analysis and neural nets. Stat Med 1994;13:1189-1200.
111. Ravdin PM, Clark GM. A practical application of neural network analysis for predicting outcome on individual breast cancer patients. Breast Cancer Res Treat 1992; 22:285-293.
112. Ravdin PM, Clark GM, Hilsenbeck SG, Owens MA, Vendely P, Pandian MR, McGuire WL. A demonstration that breast cancer recurrence can be predicted by neural network analysis. Breast Cancer Res Treat 1992;21:47-53.
113. De Laurentiis M, Ravdin PM. Survival analysis of censored data: neural network analysis detection of complex interactions between variables. Breast Cancer Res Treat1994;32:113-118.
114. Burke HB. Artificial neural networks for cancer research: outcome prediction. Semin Surg Oncol 1994;10:73-79.
115. McGuire WL, Tandon AK, Allred, DC, Chamness GC, Ravdin PM, Clark GM. Treatment decisions in axillary node-negative breast cancer patients. Monogr Natl Cancer Inst 1992;11:173-180.
116. Kappen HJ, Neijt JP. Neural network analysis to predict treatment outcome. Ann Oncol 1993;4(suppl):31-34.
117. Faraggi D, Simon R. A neural network model for survival data. Stat Med 1995; 14:73-82.
118. Biganzoli E, Boracchi P, Mariani L, Marubini E. Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. Stat Med 1998;17:1169-1186.
119. Ripley BD, Ripley RM. Neural networks as statistical methods in survival analysis. In: Dybowski R, Gant V, eds. Clinical Application of Artificial Neural Networks. New York: Cambridge University Press, 2001:237-255.
120. Biganzoli E, Boracchi P, Marubini E. A general framework for neural network models on censored survival data. Neural Networks 2002;15:209-218.
121. Ripley RM, Harris AL, Tarassenko L. Non-linear survival analysis using neural networks. Stat Med 2004;23:825-842.
122. Sauerbrei W, Hübner K, Schmoor C, Schumacher M for the German Breast Cancer Study Group. Validation of existing and development of new prognostic classification schemes in node negative breast cancer. Breast Cancer Res Treat 1997; 42:149-163.
123. Sauerbrei W, Hübner K, Schmoor C, Schumacher M for the German Breast Cancer Study Group. Validation of existing and development of new prognostic classification schemes in node negative breast cancer. Correction. Breast Cancer Res Treat 1998;48:191-192.
124. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004;23:723-748.
125. Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic classification schemes for survival data. Stat Med 1999;18:2529-2545.
126. Schumacher M, Graf E, Gerds T. How to assess prognostic models for survival data: a case study in oncology. Methods Inf Med 2003;42:564-571.
127. Parkes MC. Accuracy of predictions of survival in later stages of cancer. BMJ 1972; 264:29-31.
128. Forster LA, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med 1988;148:2540-2543.
129. Maltoni M, Pirovano M, Scarpi, E, Marinari, M, Indelli M, Arnoldi E, Galluci M, Frontini L, Piva L, Amadori D. Prediction of survival of patients terminally ill with cancer. Cancer 1995;75:2613-2622.
130. Henderson R, Jones M. Prediction in survival analysis. model or medic. In: Jewell NP, Kimber AC, Ting Lee ML, Withmore GA, eds. Lifetime Data: Models in Reliability and Survival Analysis. Dordrecht: Kluwer Academic Publishers, 1996: 125-129.
131. Henderson R. Problems and prediction in survival-data analysis. Stat Med 1995; 3:143-152.
132. Brier GW. Verification of forecasts expressed in terms of probability. Monthly Weather Rev 1950;78:1-3.
133. Hilden J, Habbema JDF, Bjerregard B. The measurement of performance in probabilistic diagnosis III: methods based on continuous functions of the diagnostic probabilities. Methods of Informations in Medicine 1978;17:238-246.
134. Hand DJ. Construction and Assessment of Classification Rules. Chichester: Wiley, 1997.
135. Shapiro AR. The evaluation of clinical predictions. N Engl J Med 1997; 296:1509-1514.
136. Korn EJ, Simon R. Explained residual variation, explained risk and goodness of fit. American Statistician 1991;45:201-206.
137. Schemper M. The explained variation in proportional hazards regression. Biometrika 1990; 77:216-218.
138. Schemper M. The explained variation in proportional hazards regression. Correction. Biometrika 1994;81:631.
139. Graf E, Schumacher M. An investigation on measures of explained variation in survival analysis. Statistician 1995;44:497-507.
140. Schemper M, Stare J. Explained variation in survival analysis. Stat Med 1996; 15:1999-2012.
141. Ash A, Schwartz M. R2: a useful measure of model performance when predicting a dichotomous outcome. Stat Med 1999;18:375-384.
142. Efron B. Estimating the error rate of prediction rule: improvement on cross-validation. JASA 1983;78:316-330.
143. Efron B, Tibshirani R. Improvement on cross-validation: the .632+ bootstrap method. JASA 1997;92:548-560.
144. Wehberg S, Schumacher M. A comparison of nonparametric error rate estimation methods in classification problems. Biometrical J. 2004;46;35-47.
145. Schoenfeld DA. Sample size formula for the proportional-hazard regression model. Biometrics 1983;39:499-503.
146. George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. J Chronic Dis 1974;27:15-24.
147. Bernstein D, Lagakos SW. Sample size and power determination for stratified clinical trials. J Stat Compu Sim 1978;8:65-73.
148. Schoenfeld DA. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981;68:316-319.
149. Schmoor, C, Sauerbrei, W, Schumacher M. Sample size considerations for the evaluation of prognostic factors in survival analysis. Stat Med 2000;19:441-452.
150. Lui K-J. Sample size determination under an exponential model in the presence of a confounder and type I censoring. Control Clin Trials 1992;13:446-458.
151. Palta M, Amini SB. Consideration of covariates and stratification in sample size determination for survival time studies. J Chronic Dis 1985;38:801-809.
152. Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per indepen dent variable in proportional hazards analysis: I. Background, goals and general strategy. J Clin Epidemiol 1995;48:1495-1501.
153. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards analysis: II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:1503-1510.
154. Harrell FE, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modeling strategies for improved prognostic prediction. Stat Med 1984;3:143-152.
155. Harrell FE, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems and suggested solutions. Cancer Treat Rep 1985; 69:1071-1077.
156. Lubin JH, Gail MJ. On power and sample size for studying features of the relative odds of disease. Am J Epidemiol 1990;131:551-566.
157. Peterson B, George SL. Sample size requirements and length of study for testing interaction in a 2 X k factorial design when time-to-failure is the outcome. Control Clin Trials 1993;14:511-522.
158. Olschewski M, Schumacher M, Davis K. Analysis of randomized and nonrandomized patients in clinical trials using the comprehensive cohort follow-up study design. Control Clin Trials 1992;13:226-239.
159. European Community, CPMP Working Party on Efficacy of Medicinal Products. Biostatistical methodology in clinical trials in applications for marketing authorisations for medicinal products. Note for Guidance III/3630/92-EN, December 1994. Stat Med 1995;14:1659-1682.
160. International Conference of Harmonisation and Technical Requirements for Registration of Pharmaceuticals for Human Drugs. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice. Recommended for Adoption at Step 4 of the ICH Process on 1 May 1996 by the ICH Steering Committee.
161. Vach, W. Logistic Regression with Missing Values in the Covariates. Lecture Notes in Statistics 86. New York: Springer 1994.
162. Vach, W. Some issues in estimating the effect of prognostic factors from incomplete covariate data. Stat Med 1997;16:57-72.
163. Robins JM, Rotnitzky A, Zhao LD. Estimation of regression coefficients when some regressors are not always observed. JASA 1994;89:846-866.
164. Lipsitz SR, Ibrahim JG. Estimating equations with incomplete categorical covariates in the Cox model. Biometrics 1998;54:1002-1013.
165. Buuren van S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999;18:681-694.